Somatic Hypermutations Enhance Neutralization Breadth of <i>IGHV3‐53/3‐66</i> Public Antibodies Against SARS‐CoV‐2 Variants

Takeo Kuwata, Kyo Okazaki, Hiroshi Morioka, Yu Kaku, Mikiko Shimizu, Yoshimi Maruyama, Ahmed K. Hamdy, Unknown, Tateki Suzuki, Takao Hashiguchi, Kei Sato, Shuzo Matsushita

Open source

DOI: 10.1002/iid3.70527
Published: 2026-09
Container: Immunity, Inflammation and Disease
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/iid3.70527,
  title = {Somatic Hypermutations Enhance Neutralization Breadth of
                    <i>IGHV3‐53/3‐66</i>
                    Public Antibodies Against SARS‐CoV‐2 Variants},
  author = {Takeo Kuwata and Kyo Okazaki and Hiroshi Morioka and Yu Kaku and Mikiko Shimizu and Yoshimi Maruyama and Ahmed K. Hamdy and Unknown and Tateki Suzuki and Takao Hashiguchi and Kei Sato and Shuzo Matsushita},
  year = {2026},
  journal = {Immunity, Inflammation and Disease},
  doi = {10.1002/iid3.70527},
  url = {https://doi.org/10.1002/iid3.70527}
}

RIS

TY  - JOUR
TI  - Somatic Hypermutations Enhance Neutralization Breadth of
                    <i>IGHV3‐53/3‐66</i>
                    Public Antibodies Against SARS‐CoV‐2 Variants
AU  - Takeo Kuwata
AU  - Kyo Okazaki
AU  - Hiroshi Morioka
AU  - Yu Kaku
AU  - Mikiko Shimizu
AU  - Yoshimi Maruyama
AU  - Ahmed K. Hamdy
AU  - Unknown
AU  - Tateki Suzuki
AU  - Takao Hashiguchi
AU  - Kei Sato
AU  - Shuzo Matsushita
PY  - 2026
JO  - Immunity, Inflammation and Disease
DO  - 10.1002/iid3.70527
UR  - https://doi.org/10.1002/iid3.70527
ER  -

APA

Kuwata, T., Okazaki, K., Morioka, H., Kaku, Y., Shimizu, M., Maruyama, Y., Hamdy, A. K., Unknown, Suzuki, T., Hashiguchi, T., Sato, K., & Matsushita, S. (2026). Somatic Hypermutations Enhance Neutralization Breadth of <i>IGHV3‐53/3‐66</i> Public Antibodies Against SARS‐CoV‐2 Variants. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70527

Source records

crossref · retrieved 2026-09-25T14:54:45.515Z